Theravance Biopharma Inc (TBPH) — Net Asset Quality Index
Theravance Biopharma Inc (TBPH) has a Net Asset Quality Index of 61.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $485.57 Million minus total liabilities of $188.85 Million yields net assets of $296.72 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read TBPH liabilities breakdown for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Theravance Biopharma Inc Net Asset Quality Index Over Time (2011–2025)
This chart shows how Theravance Biopharma Inc's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 61.1%, representing net assets of $296.72 Million against total assets of $485.57 Million USD. For live market cap and overall valuation, see TBPH market cap.
Annual Net Asset Quality Index for Theravance Biopharma Inc (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Theravance Biopharma Inc from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check TBPH capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 61.1% | $296.72 Million | $485.57 Million | $188.85 Million | ▲ +11.5 pp |
| 2024 | 49.6% | $175.54 Million | $354.16 Million | $178.62 Million | ▼ -6.2 pp |
| 2023 | 55.8% | $213.00 Million | $382.00 Million | $169.00 Million | ▼ -17.0 pp |
| 2022 | 72.7% | $441.80 Million | $607.40 Million | $165.60 Million | ▲ +163.1 pp |
| 2021 | -90.3% | $-338.57 Million | $374.82 Million | $713.39 Million | ▼ -25.6 pp |
| 2020 | -64.8% | $-303.75 Million | $469.06 Million | $772.81 Million | ▼ -10.0 pp |
| 2019 | -54.8% | $-223.84 Million | $408.83 Million | $632.67 Million | ▼ -45.5 pp |
| 2018 | -9.2% | $-51.59 Million | $560.24 Million | $611.82 Million | ▼ -35.3 pp |
| 2017 | 26.1% | $115.18 Million | $441.40 Million | $326.22 Million | ▼ -28.7 pp |
| 2016 | 54.8% | $350.23 Million | $639.25 Million | $289.02 Million | ▼ -26.2 pp |
| 2015 | 81.0% | $243.06 Million | $300.12 Million | $57.05 Million | ▼ -4.8 pp |
| 2014 | 85.8% | $289.79 Million | $337.77 Million | $47.98 Million | ▲ +153.5 pp |
| 2013 | -67.7% | $-17.04 Million | $25.18 Million | $42.21 Million | ▼ -59.5 pp |
| 2012 | -8.2% | $-1.71 Million | $20.96 Million | $22.67 Million | ▲ +1010.0 pp |
| 2011 | -1018.2% | $-140.72 Million | $13.82 Million | $154.54 Million | — |